Literature DB >> 2293904

Interaction of C1q with its receptor on cultured cell lines induces an anti-proliferative response.

B Ghebrehiwet1, G S Habicht, G Beck.   

Abstract

The receptor for human C1q (C1qR) is expressed on a wide variety of somatic cells, including cultured cell lines of different lineages such as Raji, Daudi, Wil2WT, U937, and Molt4. In this report, we present evidence which shows that culturing of C1qR-expressing cell lines with C1q inhibits their growth. When each of the different cell lines were cultured for 5 days with or without various concentrations (5-50 micrograms/ml) of micro-filtered (0.22 micron) C1q, cell proliferation was inhibited in a dose-dependent manner with maximal inhibition (90%) occurring at a concentration of 50 micrograms/ml at Day 4 of culture. This anti-proliferative effect of C1q was inhibited when 30 micrograms/ml of F(ab')2 anti-C1q was included in the culture with C1q while the antibody alone did not have any effect. The specificity of this interaction was further substantiated by the finding that neither macromolecular C1, or subcomponents C1r and C1s, nor human or murine IgG nor IgM had any inhibitory activity when cultured with these cell lines. That this C1q-induced inhibition of cell growth is mediated by C1qR was deduced from experiments in which (i) culturing of cells in the presence of two IgM monoclonal antibodies II1/D1 and II1/B5, directed against the C1q-binding site of C1qR resulted in the inhibition of cell growth while nonimmune murine IgM did not, and (ii) the collagenous portion of C1q (c-C1q) which contains the intact, C1qR-binding domain was also capable of inhibiting cell proliferation in a manner similar to intact C1q. The effect of C1q was not cytotoxic but cytostatic since the number of dead cells in the C1q-treated cultures was not significantly different than that in the untreated cells (5% vs 4%), a figure which represents the normal wear and tear of tissue culture conditions. On the basis of these findings we propose that the C1qR alone or in conjunction with other cellular factors may function as a molecule which supports cell growth. Upon ligand binding, however, the ligand-receptor interaction may suppress postreceptor events which are necessary for cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2293904     DOI: 10.1016/0090-1229(90)90014-h

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  16 in total

Review 1.  Structural and functional anatomy of the globular domain of complement protein C1q.

Authors:  Uday Kishore; Rohit Ghai; Trevor J Greenhough; Annette K Shrive; Domenico M Bonifati; Mihaela G Gadjeva; Patrick Waters; Mihaela S Kojouharova; Trinad Chakraborty; Alok Agrawal
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

2.  The classical complement pathway in transplantation: unanticipated protective effects of C1q and role in inductive antibody therapy.

Authors:  K Csencsits; B E Burrell; G Lu; E J Eichwald; G L Stahl; D K Bishop
Journal:  Am J Transplant       Date:  2008-06-28       Impact factor: 8.086

3.  SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function.

Authors:  Zhi Qiang Yao; Stephen N Waggoner; Michael W Cruise; Caroline Hall; Xuefang Xie; David W Oldach; Young S Hahn
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation.

Authors:  D J Kittlesen; K A Chianese-Bullock; Z Q Yao; T J Braciale; Y S Hahn
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 5.  C1q as an autocrine and paracrine regulator of cellular functions.

Authors:  Berhane Ghebrehiwet; Kinga H Hosszu; Ellinor I B Peerschke
Journal:  Mol Immunol       Date:  2016-11-30       Impact factor: 4.407

6.  Monocytosis and accelerated activation of lymphocytes in C1q-deficient autoimmune-prone mice.

Authors:  Marten Trendelenburg; Anthony P Manderson; Liliane Fossati-Jimack; Mark J Walport; Marina Botto
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

7.  T cell activation by soluble C1q-bearing immune complexes: implications for the pathogenesis of rheumatoid arthritis.

Authors:  K Jiang; Y Chen; C-S Xu; J N Jarvis
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

8.  Complement activation in amyloid plaques in Alzheimer's disease brains does not proceed further than C3.

Authors:  R Veerhuis; P van der Valk; I Janssen; S S Zhan; W E Van Nostrand; P Eikelenboom
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

9.  Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt.

Authors:  Zhi Qiang Yao; Audrey Eisen-Vandervelde; Stephen N Waggoner; Evan M Cale; Young S Hahn
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  The C1q family of proteins: insights into the emerging non-traditional functions.

Authors:  Berhane Ghebrehiwet; Kinga K Hosszu; Alisa Valentino; Ellinor I B Peerschke
Journal:  Front Immunol       Date:  2012-04-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.